Special Issue on Cell-Based Therapies

Biomolecules and Biomedicine

is excited to announce a call for papers for our upcoming special issue focusing on Cell-Based Therapeutics. This issue aims to showcase the transformative impacts of cell-based therapies on clinical practice and the pharmaceutical industry, featuring innovative treatments like genetically reprogrammed T cells for lymphoid cancers and adipose-derived stem cells for Crohn’s disease.


  • Yan Ma, Research Associate, Spatial Navigation and Memory Unit, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Maryland, USA.
  • Dr. Meijie Tian, NIH-funded researcher, Oncogenomic section, Genetics Branch, Center of Cancer Research, National Cancer Institute (NCI).
  • Dr. Mohd Hussain Shah, Ophthalmology Department, Ohio State University; current research fellow at National Eye Institute (NEI).

Featured Topics

  • Targeted Delivery and Biodistribution: How cell-based therapies utilize cellular properties for precise therapeutic delivery.
  • Advanced Sense-and-Response Functions: The dynamic capabilities of these therapies to monitor and respond to disease states.
  • Sustained Endogenous Drug Delivery: Exploring the persistence and long-term benefits of therapeutic cells in vivo.
  • Challenges and Solutions: Addressing the hurdles in adoption and commercialization, including cell source stability, safety, and scalable manufacturing processes.
  • Next-Generation Engineering Approaches: We are particularly interested in manuscripts discussing innovative engineering approaches such as genome and epigenome editing, synthetic biology, and biomaterial-mediated immune modulation that enhance therapeutic efficacy and address current limitations.

Purpose of This Special Issue

Our goal is to bridge the gap between basic and clinical research, enhancing the translation of groundbreaking research into clinical applications. We are looking for submissions that discuss novel methods in cell collection, isolation, modification, and production, as well as clinical applications focusing on safety, efficacy, and regulatory compliance.

Preferred Types of Submissions

  • Original studies on the characterization and utilization of therapeutic cells.
  • Reviews on molecular strategies enhancing cell-based therapeutic functions.
  • Brief communications on novel technologies and approaches in cell production.

Submission Guidelines

Submissions should demonstrate originality, relevance to genetic research and biotechnological applications, rigorous methodology, and compliance with ethical standards.

Submission Period: 15 June to 15 December 2024

Instructions for submitting the article

1. Write a Cover Letter:
   - State that you are submitting your article for the special issue on Cell-Based Therapies.
2. Select the correct Section
   - When submitting your article, choose the "Special Issue" section. This is the first option on the list.

3. Submit your article
   - Follow the steps on this link to submit your article: Submit your article


Join us in advancing the field of cell-based therapies by contributing your groundbreaking research to this special issue. Your work will be handled by well-known experts in the field, ensuring thorough review and wide recognition.